Stock & Company Details
Aptevo Therapeutics Inc $APVO
Price:
N/A
N/A
1.8M
$4.4M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.01
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
APVO technical indicators
Latest Aptevo Therapeutics Inc (APVO) indicator readings as of 2026-08-28.
APVO's 14-day RSI is 23.2, in oversold territory. At $2.37 it is trading 49.0% below its 200-day moving average of $4.63, and below its 50-day average of $3.94. Price sits near the lower Bollinger Band ($1.82 to $4.62). ADX reads 41.5, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies for the treatment of cancer. The Company's lead clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed based on the Company's versatile and robust ADAPTIR™ modular protein technology platform. The ADAPTIR™ platform is capable of generating highly differentiated bispecific antibodies with unique mechanisms of action for the treatment of different types of cancer.
Finance Bot
Ask your questions
Start by typing a question below.
